Hepatitis C Main Forums > Hepatitis C Research News & Studies
Hep C Drugs Could Add $300 to Everyone’s Yearly Insurance Premium
(1/1)
Hep Editors:
A new analysis—penned by executives at CVS Caremark argues that Sovaldi’s $1,000-per-pill price tag (or $86,000 for 12 weeks of treatment) could devastate the finances of both pharmacy benefit managers and everyday insurance-holders across the country. The commentary estimates that 3 million people in the United States living with hepatitis C may currently be eligible for treatment.